icp-490
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 29, 2023 (NCT05719701)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Zinc finger protein AiolosDEGRADER
IKZF3 degrader
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06845241 | Phase 1/Phase 2 (Phase 2) | Feb 28, 2025 | Beijing InnoCare Pharma Tech Co., Ltd. |
| NCT05719701 | Phase 1/Phase 2 (Phase 2) | Mar 29, 2023 | Beijing InnoCare Pharma Tech Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beijing InnoCare Pharma Tech Co., Ltd. | For profit | 2 | 2 | 1 | 2023 |
1 organizations
Page 1 / 1